Although PTHrP and RANKL have been reported to be associated with NSCLC bone metastasis,69, 70 therapy efficiency of treatment targeting RANKL on NSCLC bone metastases is extremely limited. The gene discussed is PTHLH; the disease is non-small cell lung carcinoma.